| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.564 | 0.012 | 0.564 | GABA C receptor rho-3 antagonist | 0.383 0.069 CID_16303 | ||
| 0.552 | 0.013 | 0.552 | Calcium channel L-type activator | 0.489 0.032 CID_16303 | ||
| 0.543 | 0.018 | 0.543 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.541 0.018 CID_16303 | ||
| 0.526 | 0.021 | 0.526 | Aryl hydrocarbon receptor agonist | 0.49 0.025 CID_16303 | ||
| 0.486 | 0.011 | 0.486 | Peroxidase inhibitor | 0.208 0.057 CID_16303 | ||
| 0.446 | 0.037 | 0.446 | 5 Hydroxytryptamine release stimulant | 0.179 0.142 CID_16303 | ||
| 0.417 | 0.019 | 0.417 | Calcium channel activator | 0.31 0.082 CID_16303 | ||
| 0.434 | 0.059 | 0.537 | 5 Hydroxytryptamine release inhibitor | 0.537 0.022 CID_16303 | CID_16303 | |
| 0.397 | 0.027 | 0.397 | Superoxide dismutase inhibitor | 0.207 0.11 CID_16303 | ||
| 0.389 | 0.019 | 0.389 | RNA-directed DNA polymerase inhibitor | 0.259 0.044 CID_16303 | ||
| 0.373 | 0.007 | 0.373 | MAP kinase 9 inhibitor | |||
| 0.399 | 0.038 | 0.447 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.447 0.028 CID_16303 | CID_16303 | |
| 0.395 | 0.048 | 0.395 | Aldehyde oxidase inhibitor | |||
| 0.364 | 0.022 | 0.364 | Anesthetic general | 0.354 0.023 CID_16303 | ||
| 0.343 | 0.005 | 0.347 | Ferrochelatase inhibitor | 0.347 0.005 CID_16303 | CID_16303 | |
| 0.34 | 0.013 | 0.34 | Gastrin inhibitor | 0.334 0.015 CID_16303 | ||
| 0.323 | 0.005 | 0.323 | MAP kinase kinase 3 inhibitor | 0.205 0.109 CID_16303 | ||
| 0.396 | 0.078 | 0.482 | Histamine release inhibitor | 0.482 0.035 CID_16303 | CID_16303 | |
| 0.309 | 0.007 | 0.309 | DNA directed RNA polymerase inhibitor | 0.112 0.044 CID_16303 | ||
| 0.303 | 0.012 | 0.303 | Anesthetic local | 0.259 0.018 CID_16303 | ||
| 0.307 | 0.018 | 0.307 | Protein-tyrosine kinase Lyn inhibitor | 0.116 0.088 CID_16303 | ||
| 0.287 | 0.009 | 0.287 | Carbonic anhydrase XV inhibitor | 0.205 0.018 CID_16303 | ||
| 0.289 | 0.014 | 0.289 | Nitric-oxide synthase stimulant | 0.242 0.038 CID_16303 | ||
| 0.311 | 0.039 | 0.311 | 5 Hydroxytryptamine uptake stimulant | 0.239 0.092 CID_16303 | ||
| 0.294 | 0.029 | 0.294 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.16 0.11 CID_16303 | ||
| 0.272 | 0.008 | 0.272 | MAP kinase 8 inhibitor | |||
| 0.301 | 0.039 | 0.301 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.162 0.128 CID_16303 | ||
| 0.345 | 0.084 | 0.345 | Prostaglandin dehydrogenase inhibitor | 0.254 0.125 CID_16303 | ||
| 0.306 | 0.046 | 0.306 | Pyruvate kinase inhibitor | 0.213 0.074 CID_16303 | ||
| 0.351 | 0.092 | 0.351 | MAP kinase kinase 6 inhibitor | |||
| 0.281 | 0.024 | 0.281 | Neurotrophic factor enhancer | 0.217 0.061 CID_16303 | ||
| 0.283 | 0.029 | 0.283 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.262 0.038 CID_16303 | ||
| 0.291 | 0.037 | 0.291 | Tyrosine 3 hydroxylase inhibitor | 0.243 0.075 CID_16303 | ||
| 0.273 | 0.02 | 0.273 | Lck kinase inhibitor | 0.146 0.068 CID_16303 | ||
| 0.264 | 0.012 | 0.264 | GABA C receptor agonist | 0.115 0.053 CID_16303 | ||
| 0.271 | 0.02 | 0.271 | Heat shock protein 90 alpha antagonist | 0.221 0.038 CID_16303 | ||
| 0.26 | 0.01 | 0.26 | Mannose-6-phosphate isomerase inhibitor | 0.167 0.051 CID_16303 | ||
| 0.276 | 0.027 | 0.276 | LIM domain kinase 1 inhibitor | 0.225 0.051 CID_16303 | ||
| 0.287 | 0.039 | 0.295 | 5 Hydroxytryptamine 1E antagonist | 0.295 0.033 CID_16303 | CID_16303 | |
| 0.259 | 0.021 | 0.515 | Alpha-N-acetylglucosaminidase inhibitor | 0.515 0.005 CID_16303 | CID_16303 | |
| 0.265 | 0.031 | 0.265 | Protein kinase C nu inhibitor | |||
| 0.336 | 0.108 | 0.336 | 15-Lipoxygenase inhibitor | 0.269 0.15 CID_16303 | ||
| 0.3 | 0.074 | 0.378 | Interleukin 2 agonist | 0.378 0.034 CID_16303 | CID_16303 | |
| 0.228 | 0.008 | 0.228 | HIV-1 reverse transcriptase inhibitor | 0.085 0.039 CID_16303 | ||
| 0.285 | 0.068 | 0.304 | Insulysin inhibitor | 0.304 0.056 CID_16303 | CID_16303 | |
| 0.304 | 0.088 | 0.304 | Cholesterol antagonist | 0.201 0.163 CID_16303 | ||
| 0.239 | 0.024 | 0.239 | Heat shock protein 90 antagonist | 0.167 0.058 CID_16303 | ||
| 0.225 | 0.011 | 0.225 | CF transmembrane conductance regulator agonist | 0.214 0.015 CID_16303 | ||
| 0.274 | 0.062 | 0.366 | Interleukin agonist | 0.366 0.025 CID_16303 | CID_16303 | |
| 0.259 | 0.048 | 0.289 | Neuropeptide Y2 antagonist | 0.289 0.025 CID_16303 | CID_16303 | |
| 0.268 | 0.056 | 0.268 | DNA synthesis inhibitor | 0.189 0.139 CID_16303 | ||
| 0.258 | 0.048 | 0.258 | ErbB-1 antagonist | 0.199 0.09 CID_16303 | ||
| 0.245 | 0.035 | 0.245 | Lipocortins synthesis antagonist | |||
| 0.258 | 0.05 | 0.258 | MAP kinase kinase 2 inhibitor | 0.197 0.084 CID_16303 | ||
| 0.218 | 0.01 | 0.218 | Porphobilinogen synthase inhibitor | 0.151 0.02 CID_16303 | ||
| 0.208 | 0.005 | 0.208 | NMDA 2C receptor antagonist | 0.124 0.01 CID_16303 | ||
| 0.212 | 0.012 | 0.212 | 5 Hydroxytryptamine 3A agonist | 0.108 0.067 CID_16303 | ||
| 0.219 | 0.02 | 0.219 | Cystathionine beta-synthase inhibitor | 0.121 0.057 CID_16303 | ||
| 0.218 | 0.02 | 0.218 | GABA C receptor rho-2 antagonist | 0.141 0.087 CID_16303 | ||
| 0.226 | 0.031 | 0.268 | 5 Hydroxytryptamine 3E antagonist | 0.268 0.01 CID_16303 | CID_16303 | |
| 0.202 | 0.011 | 0.202 | Triose-phosphate isomerase inhibitor | 0.183 0.013 CID_16303 | ||
| 0.197 | 0.006 | 0.197 | Toll-Like receptor 3 antagonist | 0.117 0.031 CID_16303 | ||
| 0.199 | 0.012 | 0.199 | HIV-1 integrase (Overall Integration) inhibitor | 0.092 0.063 CID_16303 | ||
| 0.199 | 0.013 | 0.199 | GABA C receptor antagonist | 0.108 0.067 CID_16303 | ||
| 0.196 | 0.01 | 0.196 | Nitric-oxide synthase inhibitor | 0.092 0.075 CID_16303 | ||
| 0.299 | 0.115 | 0.452 | Calpain 2 inhibitor | 0.452 0.038 CID_16303 | CID_16303 | |
| 0.211 | 0.035 | 0.211 | Interleukin 6 antagonist | |||
| 0.213 | 0.039 | 0.213 | Succinate dehydrogenase inhibitor | 0.194 0.054 CID_16303 | ||
| 0.205 | 0.032 | 0.28 | Hexokinase inhibitor | 0.28 0.013 CID_16303 | CID_16303 | |
| 0.27 | 0.097 | 0.287 | 12-Lipoxygenase inhibitor | 0.287 0.088 CID_16303 | CID_16303 | |
| 0.205 | 0.033 | 0.212 | ATPase inhibitor | 0.212 0.028 CID_16303 | CID_16303 | |
| 0.215 | 0.044 | 0.277 | 3C-like protease (Human coronavirus) inhibitor | 0.277 0.017 CID_16303 | CID_16303 | |
| 0.217 | 0.047 | 0.217 | Histone acetyltransferase inhibitor | 0.173 0.109 CID_16303 | ||
| 0.176 | 0.007 | 0.176 | Biliverdin reductase inhibitor | 0.11 0.016 CID_16303 | ||
| 0.181 | 0.012 | 0.181 | GABA C receptor rho-1 antagonist | 0.106 0.055 CID_16303 | ||
| 0.229 | 0.059 | 0.229 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.206 | 0.04 | 0.206 | Phospholipase C inhibitor | 0.161 0.086 CID_16303 | ||
| 0.179 | 0.015 | 0.248 | Sphingosine 1-phosphate receptor 4 antagonist | 0.248 0.005 CID_16303 | CID_16303 | |
| 0.239 | 0.075 | 0.239 | Angiogenesis stimulant | |||
| 0.317 | 0.154 | 0.498 | DNA directed DNA polymerase inhibitor | 0.498 0.083 CID_16303 | CID_16303 | |
| 0.319 | 0.155 | 0.526 | DNA polymerase beta inhibitor | 0.526 0.079 CID_16303 | CID_16303 | |
| 0.175 | 0.013 | 0.175 | NADH dehydrogenase inhibitor | 0.101 0.043 CID_16303 | ||
| 0.191 | 0.031 | 0.191 | MAP kinase kinase inhibitor | |||
| 0.216 | 0.057 | 0.216 | Sigma receptor agonist | 0.16 0.079 CID_16303 | ||
| 0.196 | 0.037 | 0.196 | Arachidonic acid antagonist | 0.145 0.095 CID_16303 | ||
| 0.181 | 0.023 | 0.199 | Sphingosine 1-phosphate receptor 5 antagonist | 0.199 0.012 CID_16303 | CID_16303 | |
| 0.195 | 0.037 | 0.195 | Neurotensin receptor agonist | 0.176 0.054 CID_16303 | ||
| 0.17 | 0.013 | 0.17 | Ca2+-transporting ATPase inhibitor | 0.148 0.047 CID_16303 | ||
| 0.162 | 0.006 | 0.162 | GABA aminotransferase inhibitor | 0.096 0.03 CID_16303 | ||
| 0.181 | 0.025 | 0.181 | Adenylate cyclase stimulant | 0.135 0.091 CID_16303 | ||
| 0.197 | 0.043 | 0.197 | Protein kinase stimulant | 0.155 0.065 CID_16303 | ||
| 0.182 | 0.029 | 0.182 | Cathepsin H inhibitor | 0.158 0.04 CID_16303 | ||
| 0.323 | 0.17 | 0.393 | Caspase 9 stimulant | 0.393 0.115 CID_16303 | CID_16303 | |
| 0.17 | 0.018 | 0.175 | Heat shock protein 70 antagonist | 0.175 0.014 CID_16303 | CID_16303 | |
| 0.157 | 0.005 | 0.157 | Potassium channel (ATP-sensitive) blocker | 0.122 0.008 CID_16303 | ||
| 0.211 | 0.059 | 0.211 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.173 | 0.022 | 0.176 | Carbonic anhydrase III inhibitor | 0.176 0.021 CID_16303 | CID_16303 | |
| 0.164 | 0.013 | 0.164 | Inducible nitric-oxide synthase inhibitor | |||
| 0.162 | 0.012 | 0.162 | MAP kinase kinase 1 inhibitor | 0.118 0.037 CID_16303 | ||
| 0.159 | 0.011 | 0.159 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.072 0.065 CID_16303 | ||
| 0.158 | 0.01 | 0.158 | Interleukin 12 antagonist | 0.121 0.028 CID_16303 | ||
| 0.202 | 0.053 | 0.202 | Src kinase inhibitor | 0.115 0.113 CID_16303 | ||
| 0.301 | 0.154 | 0.464 | Transcription factor inhibitor | 0.464 0.086 CID_16303 | CID_16303 | |
| 0.169 | 0.022 | 0.2 | Sphingosine 1-phosphate receptor 2 antagonist | 0.2 0.008 CID_16303 | CID_16303 | |
| 0.166 | 0.021 | 0.166 | Adenylate kinase inhibitor | 0.1 0.067 CID_16303 | ||
| 0.208 | 0.064 | 0.208 | I kappa B kinase epsilon inhibitor | 0.155 0.114 CID_16303 | ||
| 0.237 | 0.096 | 0.334 | Transcription factor STAT inhibitor | 0.334 0.04 CID_16303 | CID_16303 | |
| 0.155 | 0.015 | 0.155 | CYP2A6 inhibitor | |||
| 0.188 | 0.048 | 0.188 | Amylase inhibitor | |||
| 0.161 | 0.022 | 0.161 | Gastric antisecretory | 0.123 0.041 CID_16303 | ||
| 0.186 | 0.047 | 0.186 | Interferon gamma antagonist | 0.167 0.059 CID_16303 | ||
| 0.161 | 0.024 | 0.22 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.22 0.013 CID_16303 | CID_16303 | |
| 0.203 | 0.067 | 0.209 | Focal adhesion kinase 2 inhibitor | 0.209 0.063 CID_16303 | CID_16303 | |
| 0.179 | 0.043 | 0.179 | Hemostatic | 0.147 0.072 CID_16303 | ||
| 0.152 | 0.016 | 0.152 | NMDA 2 receptor antagonist | 0.08 0.044 CID_16303 | ||
| 0.196 | 0.06 | 0.196 | Amyloid beta precursor protein antagonist | |||
| 0.16 | 0.025 | 0.186 | TRPA1 agonist | 0.186 0.014 CID_16303 | CID_16303 | |
| 0.159 | 0.027 | 0.21 | Papain-like protease (SARS coronavirus) inhibitor | 0.21 0.009 CID_16303 | CID_16303 | |
| 0.137 | 0.005 | 0.137 | H+/K+-transporting ATPase inhibitor | |||
| 0.152 | 0.023 | 0.152 | Creatine kinase inhibitor | 0.105 0.054 CID_16303 | ||
| 0.254 | 0.125 | 0.254 | Transcription factor NF kappa B inhibitor | 0.248 0.129 CID_16303 | ||
| 0.156 | 0.027 | 0.181 | UDP-glucose 4-epimerase inhibitor | 0.181 0.021 CID_16303 | CID_16303 | |
| 0.156 | 0.028 | 0.156 | Photosensitizer | 0.102 0.084 CID_16303 | ||
| 0.209 | 0.081 | 0.217 | EphB2 antagonist | 0.217 0.077 CID_16303 | CID_16303 | |
| 0.148 | 0.02 | 0.16 | Electrolyte absorption antagonist | 0.16 0.016 CID_16303 | CID_16303 | |
| 0.132 | 0.006 | 0.132 | Estrogen-related receptor beta agonist | 0.094 0.034 CID_16303 | ||
| 0.171 | 0.046 | 0.171 | Nav1.2 sodium channel blocker | 0.139 0.064 CID_16303 | ||
| 0.18 | 0.058 | 0.18 | Polo-like kinase-3 inhibitor | |||
| 0.15 | 0.028 | 0.15 | Potassium channel (Ca-activated) activator | 0.08 0.075 CID_16303 | ||
| 0.202 | 0.081 | 0.202 | Anticonvulsant | |||
| 0.174 | 0.053 | 0.174 | Protein kinase (CK1) gamma 1 inhibitor | 0.12 0.097 CID_16303 | ||
| 0.13 | 0.01 | 0.13 | Purinergic P2X1 antagonist | 0.063 0.039 CID_16303 | ||
| 0.125 | 0.005 | 0.125 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.079 0.039 CID_16303 | ||
| 0.146 | 0.026 | 0.146 | Transcription factor STAT6 inhibitor | 0.137 0.036 CID_16303 | ||
| 0.234 | 0.115 | 0.234 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.136 | 0.018 | 0.136 | Glutamate dehydrogenase inhibitor | 0.098 0.032 CID_16303 | ||
| 0.141 | 0.023 | 0.141 | Carbonic anhydrase VI inhibitor | 0.101 0.039 CID_16303 | ||
| 0.134 | 0.02 | 0.162 | Potassium channel (Voltage-sensitive) activator | 0.162 0.01 CID_16303 | CID_16303 | |
| 0.141 | 0.028 | 0.161 | Urease inhibitor | 0.161 0.018 CID_16303 | CID_16303 | |
| 0.158 | 0.046 | 0.158 | Nav1.6 sodium channel blocker | |||
| 0.156 | 0.044 | 0.156 | Aldehyde dehydrogenase inhibitor | |||
| 0.175 | 0.064 | 0.175 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.153 | 0.043 | 0.153 | Adenylate cyclase inhibitor | |||
| 0.192 | 0.081 | 0.192 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.19 | 0.081 | 0.19 | Death-associated protein kinase 3 inhibitor | |||
| 0.159 | 0.05 | 0.159 | Toll-Like receptor antagonist | |||
| 0.121 | 0.013 | 0.121 | D-Ala-D-Ala ligase inhibitor | 0.093 0.039 CID_16303 | ||
| 0.17 | 0.062 | 0.265 | Cytidine deaminase inhibitor | 0.265 0.025 CID_16303 | CID_16303 | |
| 0.155 | 0.049 | 0.208 | Toll-Like receptor 2 antagonist | 0.208 0.02 CID_16303 | CID_16303 | |
| 0.125 | 0.019 | 0.125 | Glutamate release inhibitor | |||
| 0.141 | 0.036 | 0.183 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.183 0.025 CID_16303 | CID_16303 | |
| 0.152 | 0.047 | 0.202 | Cyclooxygenase 3 inhibitor | 0.202 0.018 CID_16303 | CID_16303 | |
| 0.176 | 0.071 | 0.176 | Tumour necrosis factor antagonist | |||
| 0.121 | 0.016 | 0.121 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.118 | 0.015 | 0.118 | T cell inhibitor | 0.097 0.028 CID_16303 | ||
| 0.114 | 0.011 | 0.152 | NMDA receptor glycine site agonist | 0.152 0.004 CID_16303 | CID_16303 | |
| 0.117 | 0.014 | 0.117 | Glycine receptor agonist | 0.074 0.048 CID_16303 | ||
| 0.127 | 0.024 | 0.127 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.157 | 0.055 | 0.157 | Neuropeptide Y1 antagonist | 0.155 0.057 CID_16303 | ||
| 0.127 | 0.026 | 0.127 | ABCA1 expression enhancer | |||
| 0.242 | 0.142 | 0.242 | Vasodilator, coronary | |||
| 0.123 | 0.024 | 0.123 | Phosphofructokinase-1 inhibitor | |||
| 0.233 | 0.135 | 0.433 | Thyroid hormone antagonist | 0.433 0.047 CID_16303 | CID_16303 | |
| 0.125 | 0.027 | 0.125 | Histamine N-methyltransferase inhibitor | |||
| 0.106 | 0.008 | 0.106 | Glutamate (mGluR7) antagonist | 0.076 0.032 CID_16303 | ||
| 0.139 | 0.042 | 0.139 | Interleukin 8 antagonist | 0.106 0.084 CID_16303 | ||
| 0.131 | 0.033 | 0.131 | Acetylcholine release stimulant | 0.106 0.074 CID_16303 | ||
| 0.14 | 0.044 | 0.14 | Microtubule formation inhibitor | 0.105 0.082 CID_16303 | ||
| 0.115 | 0.019 | 0.115 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.139 | 0.043 | 0.139 | Aminopeptidase B inhibitor | 0.103 0.063 CID_16303 | ||
| 0.124 | 0.028 | 0.124 | Carbonic anhydrase XIII inhibitor | 0.101 0.037 CID_16303 | ||
| 0.238 | 0.143 | 0.331 | Thioredoxin glutathione reductase inhibitor | 0.331 0.085 CID_16303 | CID_16303 | |
| 0.099 | 0.005 | 0.099 | Sodium/calcium exchanger inhibitor | |||
| 0.149 | 0.055 | 0.182 | NADPH oxidase inhibitor | 0.182 0.04 CID_16303 | CID_16303 | |
| 0.119 | 0.026 | 0.119 | Histidine decarboxylase inhibitor | |||
| 0.128 | 0.037 | 0.128 | DOPA decarboxylase inhibitor | |||
| 0.117 | 0.028 | 0.12 | Bcr-Abl kinase inhibitor | 0.12 0.026 CID_16303 | CID_16303 | |
| 0.106 | 0.017 | 0.148 | NMDA receptor agonist | 0.148 0.008 CID_16303 | CID_16303 | |
| 0.096 | 0.008 | 0.096 | Potassium channel (Inward rectifier) blocker | 0.072 0.016 CID_16303 | ||
| 0.091 | 0.003 | 0.091 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.018 CID_16303 | ||
| 0.213 | 0.125 | 0.232 | Streptokinase A inhibitor | 0.232 0.114 CID_16303 | CID_16303 | |
| 0.119 | 0.032 | 0.119 | Thioredoxin inhibitor | |||
| 0.137 | 0.05 | 0.137 | Beta amyloid protein antagonist | |||
| 0.095 | 0.008 | 0.095 | Transcription factor RelA inhibitor | 0.069 0.031 CID_16303 | ||
| 0.119 | 0.033 | 0.189 | Potassium channel activator | 0.189 0.01 CID_16303 | CID_16303 | |
| 0.265 | 0.179 | 0.437 | Alpha-glucosidase inhibitor | 0.437 0.1 CID_16303 | CID_16303 | |
| 0.103 | 0.017 | 0.103 | Alcohol oxidase inhibitor | 0.084 0.023 CID_16303 | ||
| 0.103 | 0.018 | 0.126 | CC chemokine 5 receptor agonist | 0.126 0.007 CID_16303 | CID_16303 | |
| 0.222 | 0.137 | 0.428 | Thyroid hormone beta antagonist | 0.428 0.046 CID_16303 | CID_16303 | |
| 0.151 | 0.067 | 0.151 | MAP kinase 3 inhibitor | 0.15 0.067 CID_16303 | ||
| 0.096 | 0.012 | 0.096 | Glutamate (mGluR6) antagonist | 0.065 0.05 CID_16303 | ||
| 0.133 | 0.05 | 0.133 | DNA repair enzyme inhibitor | 0.109 0.098 CID_16303 | ||
| 0.169 | 0.087 | 0.169 | MAP kinase kinase 5 inhibitor | |||
| 0.097 | 0.014 | 0.097 | NMDA 2A receptor antagonist | |||
| 0.112 | 0.029 | 0.112 | MAP kinase 11 inhibitor | 0.083 0.046 CID_16303 | ||
| 0.087 | 0.005 | 0.087 | Adenylate cyclase 1 inhibitor | 0.059 0.019 CID_16303 | ||
| 0.111 | 0.03 | 0.111 | Bile acid receptor antagonist | 0.103 0.044 CID_16303 | ||
| 0.12 | 0.039 | 0.12 | Anabolic | 0.11 0.05 CID_16303 | ||
| 0.206 | 0.126 | 0.325 | Transcription factor STAT3 inhibitor | 0.325 0.042 CID_16303 | CID_16303 | |
| 0.148 | 0.069 | 0.148 | Protein kinase (CK1) gamma inhibitor | |||
| 0.144 | 0.066 | 0.158 | Pregnane X receptor agonist | 0.158 0.04 CID_16303 | CID_16303 | |
| 0.086 | 0.008 | 0.121 | Dihydroorotate oxidase inhibitor | 0.121 0.004 CID_16303 | CID_16303 | |
| 0.114 | 0.036 | 0.145 | Androgen antagonist | 0.145 0.024 CID_16303 | CID_16303 | |
| 0.146 | 0.068 | 0.146 | Ribosomal protein S6 kinase inhibitor | |||
| 0.091 | 0.014 | 0.103 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.103 0.009 CID_16303 | CID_16303 | |
| 0.126 | 0.049 | 0.181 | Falcipain 3 inhibitor | 0.181 0.024 CID_16303 | CID_16303 | |
| 0.147 | 0.071 | 0.147 | Lipid peroxidase inhibitor | |||
| 0.083 | 0.008 | 0.083 | Estrogen-related receptor alpha antagonist | |||
| 0.102 | 0.028 | 0.102 | Glutamate decarboxylase inhibitor | |||
| 0.078 | 0.005 | 0.078 | Dihydrofolate reductase inhibitor | 0.041 0.036 CID_16303 | ||
| 0.159 | 0.086 | 0.25 | Death-associated protein kinase 2 inhibitor | 0.25 0.013 CID_16303 | CID_16303 | |
| 0.194 | 0.121 | 0.194 | DNA damaging | |||
| 0.098 | 0.026 | 0.098 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.089 | 0.017 | 0.089 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.09 | 0.019 | 0.09 | Acyl-CoA dehydrogenase inhibitor | 0.056 0.037 CID_16303 | ||
| 0.14 | 0.069 | 0.14 | Toll-Like receptor 9 antagonist | |||
| 0.092 | 0.022 | 0.092 | MAP kinase kinase 7 inhibitor | 0.076 0.057 CID_16303 | ||
| 0.194 | 0.124 | 0.194 | Immunostimulant | 0.184 0.13 CID_16303 | ||
| 0.091 | 0.021 | 0.091 | Argininosuccinate synthase inhibitor | |||
| 0.092 | 0.023 | 0.092 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.135 | 0.066 | 0.135 | Cyclooxygenase 1 inhibitor | |||
| 0.082 | 0.013 | 0.082 | Aconitate hydratase inhibitor | 0.048 0.043 CID_16303 | ||
| 0.126 | 0.058 | 0.15 | Protein kinase (CK2) alpha inhibitor | 0.15 0.041 CID_16303 | CID_16303 | |
| 0.126 | 0.058 | 0.126 | Monophenol monooxygenase inhibitor | 0.104 0.073 CID_16303 | ||
| 0.086 | 0.018 | 0.086 | Exportin-1 inhibitor | 0.066 0.053 CID_16303 | ||
| 0.137 | 0.069 | 0.137 | Alkaline phosphatase inhibitor | 0.136 0.07 CID_16303 | ||
| 0.275 | 0.207 | 0.275 | MAP kinase 1 inhibitor | 0.266 0.215 CID_16303 | ||
| 0.081 | 0.014 | 0.081 | Calcium channel P-type blocker | |||
| 0.091 | 0.024 | 0.091 | GABA B receptor agonist | 0.084 0.035 CID_16303 | ||
| 0.076 | 0.009 | 0.076 | Fructose-1,6-bisphosphatase inhibitor | 0.044 0.032 CID_16303 | ||
| 0.12 | 0.053 | 0.12 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.13 | 0.064 | 0.13 | M18 aspartyl aminopeptidase inhibitor | 0.106 0.084 CID_16303 | ||
| 0.077 | 0.011 | 0.077 | Ryanodine receptor antagonist | |||
| 0.071 | 0.005 | 0.071 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.103 | 0.037 | 0.103 | Bromodomain-containing protein 2 inhibitor | 0.098 0.043 CID_16303 | ||
| 0.124 | 0.059 | 0.157 | Interleukin 1b antagonist | 0.157 0.035 CID_16303 | CID_16303 | |
| 0.069 | 0.005 | 0.069 | Glutamate (mGluR8) agonist | 0.048 0.013 CID_16303 | ||
| 0.084 | 0.021 | 0.084 | Carbonic anhydrase VB inhibitor | 0.069 0.029 CID_16303 | ||
| 0.106 | 0.043 | 0.106 | NMDA receptor antagonist | |||
| 0.168 | 0.105 | 0.225 | Growth factor agonist | 0.225 0.044 CID_16303 | CID_16303 | |
| 0.131 | 0.068 | 0.255 | M17 leucyl aminopeptidase inhibitor | 0.255 0.02 CID_16303 | CID_16303 | |
| 0.136 | 0.074 | 0.156 | Cytokine production inhibitor | 0.156 0.058 CID_16303 | CID_16303 | |
| 0.07 | 0.008 | 0.07 | Dihydropteroate synthase inhibitor | 0.052 0.016 CID_16303 | ||
| 0.093 | 0.032 | 0.093 | Aminopeptidase I inhibitor | 0.078 0.044 CID_16303 | ||
| 0.067 | 0.007 | 0.067 | Potassium channel Kv1.1 blocker | 0.065 0.007 CID_16303 | ||
| 0.106 | 0.046 | 0.106 | Alcohol dehydrogenase inhibitor | |||
| 0.099 | 0.038 | 0.099 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.129 | 0.069 | 0.129 | Vanilloid 1 agonist | 0.126 0.075 CID_16303 | ||
| 0.117 | 0.057 | 0.13 | Mucolytic | 0.13 0.046 CID_16303 | CID_16303 | |
| 0.09 | 0.03 | 0.098 | Carbonic anhydrase VA inhibitor | 0.098 0.026 CID_16303 | CID_16303 | |
| 0.097 | 0.038 | 0.097 | Myeloperoxidase inhibitor | |||
| 0.093 | 0.035 | 0.093 | Interferon agonist | |||
| 0.072 | 0.014 | 0.072 | NMDA receptor subunit 3A antagonist | |||
| 0.122 | 0.064 | 0.122 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.086 | 0.029 | 0.086 | Secretase beta inhibitor | 0.074 0.044 CID_16303 | ||
| 0.185 | 0.128 | 0.257 | Calpain inhibitor | 0.257 0.058 CID_16303 | CID_16303 | |
| 0.064 | 0.008 | 0.064 | Guanylate cyclase inhibitor | 0.038 0.036 CID_16303 | ||
| 0.082 | 0.027 | 0.082 | Aromatase inhibitor | |||
| 0.145 | 0.089 | 0.145 | Melanin inhibitor | 0.129 0.115 CID_16303 | ||
| 0.081 | 0.026 | 0.081 | 5 Hydroxytryptamine 3 agonist | |||
| 0.073 | 0.019 | 0.073 | Phosphorylase inhibitor | 0.068 0.021 CID_16303 | ||
| 0.086 | 0.032 | 0.099 | Carbonic anhydrase V inhibitor | 0.099 0.027 CID_16303 | CID_16303 | |
| 0.063 | 0.009 | 0.063 | Alpha 1d adrenoreceptor agonist | 0.05 0.017 CID_16303 | ||
| 0.064 | 0.011 | 0.064 | Geranyltranstransferase inhibitor | |||
| 0.078 | 0.025 | 0.078 | Alpha 2 adrenoreceptor agonist | |||
| 0.197 | 0.144 | 0.197 | Lipoxygenase inhibitor | |||
| 0.069 | 0.016 | 0.076 | Adenine nucleotide translocase inhibitor | 0.076 0.011 CID_16303 | CID_16303 | |
| 0.066 | 0.014 | 0.066 | Thymidylate synthase inhibitor | |||
| 0.239 | 0.187 | 0.239 | Antibacterial | |||
| 0.064 | 0.012 | 0.064 | AICAR transformylase inhibitor | 0.055 0.018 CID_16303 | ||
| 0.077 | 0.026 | 0.077 | Androgen agonist | 0.06 0.042 CID_16303 | ||
| 0.084 | 0.033 | 0.084 | MAP kinase 7 inhibitor | |||
| 0.064 | 0.014 | 0.064 | Kainate receptor antagonist | |||
| 0.073 | 0.024 | 0.073 | Corticotropin releasing factor 2 receptor antagonist | 0.067 0.033 CID_16303 | ||
| 0.081 | 0.032 | 0.081 | Potassium channel (Tandem pore domain) blocker | 0.081 0.032 CID_16303 | ||
| 0.137 | 0.088 | 0.137 | Diuretic | |||
| 0.092 | 0.044 | 0.092 | mTOR complex 2 inhibitor | |||
| 0.071 | 0.024 | 0.071 | Alpha tubulin antagonist | |||
| 0.075 | 0.028 | 0.075 | Interferon inducer | |||
| 0.074 | 0.027 | 0.074 | Maillard reaction inhibitor | 0.049 0.045 CID_16303 | ||
| 0.076 | 0.03 | 0.076 | Aryl hydrocarbon receptor antagonist | 0.067 0.041 CID_16303 | ||
| 0.075 | 0.028 | 0.075 | MDM2 inhibitor | |||
| 0.103 | 0.058 | 0.103 | Insulin receptor antagonist | |||
| 0.106 | 0.061 | 0.116 | Beta glucuronidase inhibitor | 0.116 0.05 CID_16303 | CID_16303 | |
| 0.083 | 0.039 | 0.083 | Purinergic P2X2 antagonist | |||
| 0.105 | 0.061 | 0.105 | MAO A inhibitor | 0.085 0.075 CID_16303 | ||
| 0.056 | 0.012 | 0.056 | Retinoid X alpha receptor agonist | |||
| 0.071 | 0.027 | 0.071 | Heat shock protein 90 beta antagonist | 0.057 0.046 CID_16303 | ||
| 0.077 | 0.034 | 0.077 | Histone deacetylase inhibitor | 0.064 0.048 CID_16303 | ||
| 0.056 | 0.013 | 0.077 | Potassium channel KCNQ activator | 0.077 0.005 CID_16303 | CID_16303 | |
| 0.056 | 0.013 | 0.077 | Delayed rectifier potassium channel activator | 0.077 0.005 CID_16303 | CID_16303 | |
| 0.148 | 0.106 | 0.172 | DNA methyltransferase I inhibitor | 0.172 0.085 CID_16303 | CID_16303 | |
| 0.072 | 0.03 | 0.072 | Carbonic anhydrase stimulant | 0.068 0.033 CID_16303 | ||
| 0.061 | 0.02 | 0.061 | Adenosine deaminase inhibitor | |||
| 0.056 | 0.015 | 0.056 | Retinoid X receptor agonist | |||
| 0.066 | 0.025 | 0.066 | Sphingosine kinase 2 inhibitor | |||
| 0.093 | 0.052 | 0.093 | Ornithine decarboxylase inhibitor | |||
| 0.064 | 0.024 | 0.064 | Epithelial sodium channel blocker | |||
| 0.068 | 0.028 | 0.07 | Botulinum neurotoxin type A inhibitor | 0.07 0.025 CID_16303 | CID_16303 | |
| 0.055 | 0.016 | 0.055 | Glutamate (mGluR group III) antagonist | |||
| 0.153 | 0.113 | 0.153 | Psychostimulant | |||
| 0.063 | 0.024 | 0.063 | Lysine-specific demethylase 1A inhibitor | |||
| 0.104 | 0.064 | 0.104 | Expectorant | 0.102 0.066 CID_16303 | ||
| 0.046 | 0.006 | 0.048 | Adenosine uptake inhibitor | 0.048 0.005 CID_16303 | CID_16303 | |
| 0.053 | 0.014 | 0.053 | Vascular adhesion protein 1 inhibitor | |||
| 0.089 | 0.05 | 0.089 | MAP-kinase-activated kinase inhibitor | |||
| 0.084 | 0.045 | 0.084 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.177 | 0.139 | 0.177 | Spasmolytic | |||
| 0.067 | 0.03 | 0.067 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.063 | 0.025 | 0.063 | Pregnane X receptor antagonist | 0.057 0.04 CID_16303 | ||
| 0.065 | 0.027 | 0.099 | Acetyl-CoA transferase inhibitor | 0.099 0.013 CID_16303 | CID_16303 | |
| 0.057 | 0.021 | 0.057 | Glucose-6-phosphate isomerase inhibitor | 0.051 0.028 CID_16303 | ||
| 0.051 | 0.014 | 0.051 | Inosine monophosphate dehydrogenase inhibitor | 0.045 0.018 CID_16303 | ||
| 0.15 | 0.114 | 0.15 | Non-steroidal antiinflammatory agent | |||
| 0.134 | 0.098 | 0.134 | Cyclin-dependent kinase 8 inhibitor | 0.134 0.097 CID_16303 | ||
| 0.08 | 0.044 | 0.08 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.118 | 0.082 | 0.118 | Tubulin antagonist | |||
| 0.06 | 0.025 | 0.06 | Immunoglobulin Fc receptor antagonist | 0.053 0.048 CID_16303 | ||
| 0.054 | 0.02 | 0.102 | Dihydroorotase inhibitor | 0.102 0.005 CID_16303 | CID_16303 | |
| 0.111 | 0.077 | 0.111 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.069 | 0.035 | 0.069 | Beta tubulin antagonist | |||
| 0.11 | 0.077 | 0.11 | Abl kinase inhibitor | |||
| 0.053 | 0.019 | 0.053 | Histamine H2 receptor agonist | |||
| 0.049 | 0.015 | 0.053 | Diamine oxidase inhibitor | 0.053 0.013 CID_16303 | CID_16303 | |
| 0.095 | 0.062 | 0.095 | Phosphodiesterase 6D inhibitor | |||
| 0.038 | 0.006 | 0.038 | Glutamate (mGluR1a) agonist | 0.024 0.013 CID_16303 | ||
| 0.038 | 0.006 | 0.038 | Estrogen-related receptor gamma antagonist | 0.029 0.018 CID_16303 | ||
| 0.048 | 0.016 | 0.048 | Heme oxygenase inhibitor | |||
| 0.129 | 0.097 | 0.129 | Acetylcholine M1 receptor antagonist | |||
| 0.055 | 0.024 | 0.055 | CC chemokine receptor 2B antagonist | |||
| 0.06 | 0.029 | 0.06 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.053 | 0.022 | 0.053 | Cytokine production stimulant | |||
| 0.109 | 0.079 | 0.109 | Alkylator | |||
| 0.077 | 0.047 | 0.081 | Adenosine A3 receptor antagonist | 0.081 0.041 CID_16303 | CID_16303 | |
| 0.043 | 0.014 | 0.043 | Purinergic P2Y2 antagonist | |||
| 0.097 | 0.067 | 0.122 | Glutamate (mGluR7) agonist | 0.122 0.029 CID_16303 | CID_16303 | |
| 0.046 | 0.017 | 0.046 | Retinoid X receptor antagonist | |||
| 0.048 | 0.019 | 0.048 | Dopamine D5 agonist | |||
| 0.08 | 0.051 | 0.08 | Fibroblast growth factor 3 antagonist | |||
| 0.094 | 0.065 | 0.119 | Platelet activating factor alpha antagonist | 0.119 0.046 CID_16303 | CID_16303 | |
| 0.055 | 0.027 | 0.055 | Topoisomerase II beta inhibitor | 0.048 0.035 CID_16303 | ||
| 0.108 | 0.08 | 0.108 | Calcium channel N-type blocker | |||
| 0.064 | 0.036 | 0.064 | Beta 2 adrenoreceptor agonist | 0.059 0.053 CID_16303 | ||
| 0.202 | 0.174 | 0.224 | Vasodilator, peripheral | 0.224 0.15 CID_16303 | CID_16303 | |
| 0.033 | 0.005 | 0.033 | Complement factor 1s inhibitor | |||
| 0.109 | 0.082 | 0.109 | MAO inhibitor | |||
| 0.073 | 0.046 | 0.073 | Phospholipase D inhibitor | |||
| 0.064 | 0.037 | 0.08 | Histone deacetylase SIRT3 inhibitor | 0.08 0.018 CID_16303 | CID_16303 | |
| 0.123 | 0.096 | 0.123 | Cell wall synthesis inhibitor | 0.118 0.102 CID_16303 | ||
| 0.054 | 0.028 | 0.063 | Potassium channel (Inward rectifier) activator | 0.063 0.017 CID_16303 | CID_16303 | |
| 0.043 | 0.017 | 0.043 | Fumarate hydratase inhibitor | |||
| 0.054 | 0.029 | 0.054 | Carbonic anhydrase XIV inhibitor | 0.044 0.04 CID_16303 | ||
| 0.036 | 0.011 | 0.036 | Methionyl aminopeptidase 2 inhibitor | 0.025 0.018 CID_16303 | ||
| 0.078 | 0.053 | 0.078 | Na+ K+ transporting ATPase inhibitor | |||
| 0.121 | 0.096 | 0.121 | Activin receptor-like kinase 2 inhibitor | |||
| 0.094 | 0.069 | 0.094 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.04 | 0.015 | 0.04 | Retinoid X alpha receptor antagonist | |||
| 0.05 | 0.025 | 0.05 | NMDA receptor subunit 3B antagonist | 0.041 0.033 CID_16303 | ||
| 0.052 | 0.027 | 0.06 | Potassium channel (ATP-sensitive) activator | 0.06 0.016 CID_16303 | CID_16303 | |
| 0.037 | 0.013 | 0.037 | Glutamate (mGluR3) agonist | 0.03 0.029 CID_16303 | ||
| 0.061 | 0.037 | 0.071 | Sphingosine 1-phosphate receptor 3 antagonist | 0.071 0.025 CID_16303 | CID_16303 | |
| 0.031 | 0.007 | 0.031 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.042 | 0.018 | 0.042 | Phosphoglycerate kinase inhibitor | |||
| 0.087 | 0.063 | 0.087 | Pim-3 kinase inhibitor | |||
| 0.046 | 0.022 | 0.055 | Acetyl-CoA transferase 1 inhibitor | 0.055 0.012 CID_16303 | CID_16303 | |
| 0.048 | 0.025 | 0.048 | Glutamate (mGluR group III) agonist | |||
| 0.052 | 0.029 | 0.061 | Glycine transporter 2 inhibitor | 0.061 0.024 CID_16303 | CID_16303 | |
| 0.053 | 0.031 | 0.064 | Lysophosphatidic acid 3 receptor antagonist | 0.064 0.018 CID_16303 | CID_16303 | |
| 0.045 | 0.022 | 0.045 | Histone deacetylase class I inhibitor | 0.035 0.033 CID_16303 | ||
| 0.063 | 0.041 | 0.063 | Phosphodiesterase 1C inhibitor | |||
| 0.076 | 0.054 | 0.104 | Sphingosine 1-phosphate receptor antagonist | 0.104 0.019 CID_16303 | CID_16303 | |
| 0.043 | 0.022 | 0.043 | AMPA 4 receptor antagonist | |||
| 0.065 | 0.044 | 0.074 | Protease 3C (Human rhinovirus) inhibitor | 0.074 0.032 CID_16303 | CID_16303 | |
| 0.046 | 0.024 | 0.046 | Nerve growth factor antagonist | 0.041 0.033 CID_16303 | ||
| 0.041 | 0.02 | 0.041 | Glutamate (mGluR3) antagonist | |||
| 0.056 | 0.035 | 0.056 | Toll-Like receptor 8 antagonist | |||
| 0.06 | 0.039 | 0.098 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.098 0.017 CID_16303 | CID_16303 | |
| 0.043 | 0.022 | 0.043 | TRPM8 blocker | |||
| 0.082 | 0.061 | 0.082 | Histamine H2 receptor antagonist | |||
| 0.028 | 0.008 | 0.029 | Imidazoline I1 receptor antagonist | 0.029 0.008 CID_16303 | CID_16303 | |
| 0.037 | 0.017 | 0.037 | Potassium channel small-conductance Ca-activated activator | |||
| 0.025 | 0.005 | 0.025 | Estrogen-related receptor gamma agonist | 0.019 0.011 CID_16303 | ||
| 0.031 | 0.012 | 0.037 | NMDA receptor glycine site antagonist | 0.037 0.009 CID_16303 | CID_16303 | |
| 0.151 | 0.132 | 0.157 | Insulin sensitizer | 0.157 0.124 CID_16303 | CID_16303 | |
| 0.059 | 0.04 | 0.059 | Sphingosine kinase inhibitor | |||
| 0.037 | 0.019 | 0.037 | Glutamate (mGluR4) agonist | |||
| 0.032 | 0.014 | 0.032 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.043 | 0.025 | 0.043 | Kainate receptor agonist | |||
| 0.032 | 0.015 | 0.032 | CDK4/cyclin D3 inhibitor | |||
| 0.026 | 0.009 | 0.026 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.018 0.016 CID_16303 | ||
| 0.049 | 0.032 | 0.049 | Dopamine beta hydroxylase inhibitor | |||
| 0.053 | 0.037 | 0.053 | Ornithine carbamoyltransferase inhibitor | |||
| 0.074 | 0.058 | 0.074 | Keratolytic | |||
| 0.044 | 0.028 | 0.044 | Glutamate (mGluR4) antagonist | |||
| 0.031 | 0.015 | 0.031 | Purinergic P2Y15 antagonist | 0.027 0.024 CID_16303 | ||
| 0.077 | 0.062 | 0.109 | Glycine receptor antagonist | 0.109 0.025 CID_16303 | CID_16303 | |
| 0.044 | 0.029 | 0.044 | Histamine H1 receptor agonist | |||
| 0.04 | 0.025 | 0.04 | 5 Hydroxytryptamine 2B agonist | |||
| 0.027 | 0.013 | 0.027 | Glutamate (mGluR1) agonist | |||
| 0.156 | 0.142 | 0.156 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.046 | 0.032 | 0.061 | Carbonic anhydrase VII inhibitor | 0.061 0.019 CID_16303 | CID_16303 | |
| 0.043 | 0.029 | 0.043 | GABA B receptor antagonist | |||
| 0.041 | 0.027 | 0.041 | Thymidine kinase inhibitor | |||
| 0.022 | 0.008 | 0.022 | Alpha 2c adrenoreceptor agonist | 0.021 0.009 CID_16303 | ||
| 0.058 | 0.045 | 0.069 | Cyclin D1 inhibitor | 0.069 0.03 CID_16303 | CID_16303 | |
| 0.023 | 0.01 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.047 | 0.034 | 0.047 | AMPA receptor antagonist | |||
| 0.047 | 0.034 | 0.047 | Urokinase inhibitor | |||
| 0.021 | 0.009 | 0.021 | Alpha 2a adrenoreceptor agonist | |||
| 0.194 | 0.182 | 0.194 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.027 | 0.015 | 0.027 | Vanilloid 2 agonist | |||
| 0.029 | 0.018 | 0.029 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.087 | 0.076 | 0.103 | Protein kinase (CK2) inhibitor | 0.103 0.061 CID_16303 | CID_16303 | |
| 0.191 | 0.181 | 0.235 | Angiogenesis inhibitor | 0.235 0.135 CID_16303 | CID_16303 | |
| 0.019 | 0.009 | 0.019 | CC chemokine 9 receptor antagonist | |||
| 0.031 | 0.021 | 0.058 | Epoxide hydrolase 1 inhibitor | 0.058 0.005 CID_16303 | CID_16303 | |
| 0.031 | 0.021 | 0.038 | Lysophosphatidic acid 2 receptor antagonist | 0.038 0.014 CID_16303 | CID_16303 | |
| 0.036 | 0.027 | 0.036 | Integrin alpha2 antagonist | |||
| 0.018 | 0.008 | 0.018 | CDK2/cyclin A3 inhibitor | |||
| 0.197 | 0.187 | 0.468 | Beta lactamase inhibitor | 0.468 0.082 CID_16303 | CID_16303 | |
| 0.052 | 0.043 | 0.052 | Glucosylceramidase inhibitor | |||
| 0.043 | 0.034 | 0.043 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.026 | 0.017 | 0.026 | Acid ceramidase inhibitor | |||
| 0.051 | 0.043 | 0.051 | CC chemokine 2 receptor antagonist | |||
| 0.035 | 0.027 | 0.035 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.014 | 0.006 | 0.014 | Glutamate (mGluR6) agonist | |||
| 0.03 | 0.022 | 0.03 | Acetylcholine M4 receptor agonist | |||
| 0.027 | 0.02 | 0.027 | Uridine phosphorylase inhibitor | |||
| 0.039 | 0.031 | 0.039 | Glutamate (mGluR1a) antagonist | |||
| 0.137 | 0.13 | 0.146 | DNA methylase inhibitor | 0.146 0.12 CID_16303 | CID_16303 | |
| 0.039 | 0.033 | 0.039 | Oxytocin agonist | |||
| 0.01 | 0.004 | 0.01 | DNA topoisomerase III inhibitor | 0.008 0.005 CID_16303 | ||
| 0.011 | 0.005 | 0.011 | Progesterone receptor A antagonist | |||
| 0.02 | 0.014 | 0.02 | Toll-Like receptor 8 agonist | |||
| 0.098 | 0.092 | 0.098 | c-Src kinase inhibitor | |||
| 0.05 | 0.044 | 0.058 | Nicotinic alpha3beta2 receptor antagonist | 0.058 0.028 CID_16303 | CID_16303 | |
| 0.019 | 0.013 | 0.019 | Antibiotic Anthracycline-like | |||
| 0.098 | 0.092 | 0.098 | TRKA antagonist | |||
| 0.049 | 0.044 | 0.049 | Carbonic anhydrase IX inhibitor | |||
| 0.05 | 0.045 | 0.05 | Alpha-mannosidase inhibitor | |||
| 0.074 | 0.07 | 0.074 | I kappa B kinase inhibitor | |||
| 0.126 | 0.121 | 0.126 | CDC-like kinase 4 inhibitor | |||
| 0.052 | 0.048 | 0.065 | Sphingosine 1-phosphate receptor 1 antagonist | 0.065 0.022 CID_16303 | CID_16303 | |
| 0.04 | 0.036 | 0.04 | Purinergic P2Y antagonist | |||
| 0.042 | 0.038 | 0.042 | Glutamate (mGluR5) agonist | |||
| 0.072 | 0.068 | 0.072 | Adrenaline agonist | |||
| 0.129 | 0.125 | 0.15 | Antipruritic | 0.15 0.095 CID_16303 | CID_16303 | |
| 0.044 | 0.041 | 0.048 | Benzodiazepine antagonist | 0.048 0.031 CID_16303 | CID_16303 | |
| 0.076 | 0.072 | 0.076 | Caspase 7 inhibitor | |||
| 0.017 | 0.014 | 0.017 | CXC chemokine 5 receptor antagonist | |||
| 0.034 | 0.03 | 0.034 | Glutamate (mGluR8) antagonist | |||
| 0.018 | 0.015 | 0.018 | Alpha 2b adrenoreceptor agonist | |||
| 0.025 | 0.021 | 0.025 | Thymidine phosphorylase inhibitor | |||
| 0.022 | 0.019 | 0.022 | Histone deacetylase 1 inhibitor | |||
| 0.116 | 0.113 | 0.133 | Farnesoid X receptor antagonist | 0.133 0.077 CID_16303 | CID_16303 | |
| 0.02 | 0.017 | 0.035 | Neuraminidase (Influenza B) inhibitor | 0.035 0.004 CID_16303 | CID_16303 | |
| 0.011 | 0.008 | 0.011 | Imidazoline I2 receptor antagonist | |||
| 0.02 | 0.018 | 0.036 | Protease (Human cytomegalovirus) inhibitor | 0.036 0.006 CID_16303 | CID_16303 | |
| 0.189 | 0.187 | 0.189 | Caspase 3 stimulant | |||
| 0.056 | 0.054 | 0.056 | I kappa B kinase 2 inhibitor | |||
| 0.064 | 0.062 | 0.064 | Cathepsin G inhibitor | |||
| 0.017 | 0.015 | 0.017 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.019 | 0.018 | 0.021 | Factor XIII inhibitor | 0.021 0.013 CID_16303 | CID_16303 | |
| 0.046 | 0.045 | 0.046 | CD45 antagonist | |||
| 0.042 | 0.041 | 0.042 | Glutamate (mGluR group I) agonist | |||
| 0.044 | 0.044 | 0.099 | Dihydroorotate dehydrogenase inhibitor | 0.099 0.012 CID_16303 | CID_16303 | |
| 0.012 | 0.013 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.006 CID_16303 | CID_16303 | |
| 0.052 | 0.054 | 0.058 | Leukotriene C antagonist | 0.058 0.034 CID_16303 | CID_16303 | |
| 0.098 | 0.1 | 0.15 | Nav1.3 sodium channel blocker | 0.15 0.048 CID_16303 | CID_16303 | |
| 0.045 | 0.047 | 0.055 | Factor IXa inhibitor | 0.055 0.032 CID_16303 | CID_16303 | |
| 0.023 | 0.025 | 0.03 | Thyroid hormone agonist | 0.03 0.013 CID_16303 | CID_16303 | |
| 0.06 | 0.063 | 0.108 | Prostaglandin-E synthase inhibitor | 0.108 0.023 CID_16303 | CID_16303 | |
| 0.048 | 0.052 | 0.068 | Heparanase inhibitor | 0.068 0.013 CID_16303 | CID_16303 | |
| 0.072 | 0.076 | 0.089 | Glutathione S-transferase inhibitor | 0.089 0.049 CID_16303 | CID_16303 | |
| 0.06 | 0.065 | 0.075 | Telomerase inhibitor | 0.075 0.048 CID_16303 | CID_16303 | |
| 0.044 | 0.049 | 0.053 | Carbonic anhydrase I inhibitor | 0.053 0.041 CID_16303 | CID_16303 | |
| 0.034 | 0.04 | 0.047 | Carbonic anhydrase IV inhibitor | 0.047 0.026 CID_16303 | CID_16303 | |
| 0.009 | 0.017 | 0.016 | Carbonic anhydrase XI inhibitor | 0.016 0.005 CID_16303 | CID_16303 | |
| 0.01 | 0.018 | 0.016 | Human herpes virus 5 capsid protein P40 inhibitor | 0.016 0.005 CID_16303 | CID_16303 | |
| 0.043 | 0.051 | 0.049 | Carbonic anhydrase II inhibitor | 0.049 0.045 CID_16303 | CID_16303 | |
| 0.066 | 0.076 | 0.069 | Vanilloid 4 agonist | 0.069 0.068 CID_16303 | CID_16303 | |
| 0.116 | 0.127 | 0.139 | Thiol protease inhibitor | 0.139 0.081 CID_16303 | CID_16303 | |
| 0.011 | 0.023 | 0.021 | Carbonic anhydrase X inhibitor | 0.021 0.008 CID_16303 | CID_16303 | |
| 0.011 | 0.023 | 0.021 | Carbonic anhydrase VIII inhibitor | 0.021 0.008 CID_16303 | CID_16303 | |
| 0.025 | 0.038 | 0.033 | Methionyl aminopeptidase 1 inhibitor | 0.033 0.02 CID_16303 | CID_16303 | |
| 0.012 | 0.026 | 0.021 | Nicotinic acid receptor 1 antagonist | 0.021 0.008 CID_16303 | CID_16303 | |
| 0.046 | 0.061 | 0.054 | Carbonic anhydrase inhibitor | 0.054 0.051 CID_16303 | CID_16303 | |
| 0.034 | 0.049 | 0.037 | Leukotriene C4 antagonist | 0.037 0.032 CID_16303 | CID_16303 | |
| 0.02 | 0.036 | 0.026 | Nicotinic acid receptor 2 antagonist | 0.026 0.02 CID_16303 | CID_16303 | |
| 0.013 | 0.03 | 0.019 | Apolipoprotein B-100 inhibitor | 0.019 0.011 CID_16303 | CID_16303 | |
| 0.032 | 0.05 | 0.038 | Leukocyte elastase inhibitor | 0.038 0.036 CID_16303 | CID_16303 | |
| 0.03 | 0.049 | 0.039 | MAP3K5 inhibitor | 0.039 0.027 CID_16303 | CID_16303 | |
| 0.077 | 0.097 | 0.112 | Mediator release inhibitor | 0.112 0.055 CID_16303 | CID_16303 | |
| 0.015 | 0.04 | 0.026 | Cyclin E2 inhibitor | 0.026 0.022 CID_16303 | CID_16303 | |
| 0.054 | 0.079 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.064 0.045 CID_16303 | CID_16303 | |
| 0.035 | 0.063 | 0.042 | Purinergic P2X4 antagonist | 0.042 0.04 CID_16303 | CID_16303 | |
| 0.025 | 0.055 | 0.047 | Histone deacetylase 8 inhibitor | 0.047 0.024 CID_16303 | CID_16303 | |
| 0.049 | 0.081 | 0.131 | Catalase inhibitor | 0.131 0.03 CID_16303 | CID_16303 | |
| 0.026 | 0.059 | 0.054 | CDK5/p25 inhibitor | 0.054 0.019 CID_16303 | CID_16303 | |
| 0.081 | 0.116 | 0.12 | Proteasome inhibitor | 0.12 0.065 CID_16303 | CID_16303 | |
| 0.091 | 0.128 | 0.107 | Interleukin 2 antagonist | 0.107 0.071 CID_16303 | CID_16303 | |
| 0.084 | 0.123 | 0.133 | Caspase 3 inhibitor | 0.133 0.043 CID_16303 | CID_16303 | |
| 0.051 | 0.092 | 0.087 | Epoxide hydrolase inhibitor | 0.087 0.035 CID_16303 | CID_16303 | |
| 0.072 | 0.114 | 0.093 | Interleukin 1 beta converting enzyme inhibitor | 0.093 0.067 CID_16303 | CID_16303 | |
| 0.094 | 0.139 | 0.126 | Antibacterial (Helicobacter pylori) | 0.126 0.073 CID_16303 | CID_16303 | |
| 0.017 | 0.065 | 0.044 | Nicotinic acid receptor agonist | 0.044 0.017 CID_16303 | CID_16303 | |
| 0.039 | 0.088 | 0.064 | Fatty acid synthase inhibitor | 0.064 0.031 CID_16303 | CID_16303 | |
| 0.022 | 0.097 | 0.072 | Smo receptor antagonist | 0.072 0.014 CID_16303 | CID_16303 | |
| 0.082 | 0.159 | 0.12 | Interleukin 4 antagonist | 0.12 0.085 CID_16303 | CID_16303 | |
| 0.082 | 0.16 | 0.166 | Histone deacetylase SIRT1 inhibitor | 0.166 0.049 CID_16303 | CID_16303 | |
| 0.049 | 0.13 | 0.087 | Stem cell growth factor agonist | 0.087 0.058 CID_16303 | CID_16303 | |
| 0.095 | 0.177 | 0.14 | NOS3 expression enhancer | 0.14 0.083 CID_16303 | CID_16303 | |
| 0.035 | 0.118 | 0.084 | Vanilloid antagonist | 0.084 0.044 CID_16303 | CID_16303 | |
| 0.011 | 0.098 | 0.021 | Potassium channel (Inward rectifier) 11 blocker | 0.021 0.008 CID_16303 | CID_16303 | |
| 0.17 | 0.26 | 0.227 | Ca(v)3.3 blocker | 0.227 0.139 CID_16303 | CID_16303 | |
| 0.07 | 0.165 | 0.116 | Hedgehog signaling inhibitor | 0.116 0.044 CID_16303 | CID_16303 | |
| 0.036 | 0.136 | 0.054 | DNA helicase inhibitor | 0.054 0.039 CID_16303 | CID_16303 | |
| 0.099 | 0.208 | 0.131 | Death-associated protein kinase 1 inhibitor | 0.131 0.079 CID_16303 | CID_16303 | |
| 0.012 | 0.161 | 0.028 | Cyclophilin A inhibitor | 0.028 0.026 CID_16303 | CID_16303 | |
| 0.082 | 0.233 | 0.243 | Interleukin antagonist | 0.243 0.064 CID_16303 | CID_16303 | |
| 0.017 | 0.19 | 0.042 | Nicotinic acid receptor 1 agonist | 0.042 0.026 CID_16303 | CID_16303 | |
| 0.026 | 0.202 | 0.073 | Histone deacetylase SIRT2 inhibitor | 0.073 0.051 CID_16303 | CID_16303 | |
| 0.017 | 0.202 | 0.082 | Neuraminidase (Influenza A) inhibitor | 0.082 0.005 CID_16303 | CID_16303 | |
| 0.044 | 0.246 | 0.116 | Histone deacetylase class III inhibitor | 0.116 0.073 CID_16303 | CID_16303 | |
| 0.059 | 0.262 | 0.151 | CDK3/cyclin E inhibitor | 0.151 0.026 CID_16303 | CID_16303 | |
| 0.112 | 0.347 | 0.221 | Peptidyltransferase inhibitor | 0.221 0.075 CID_16303 | CID_16303 | |
| 0.019 | 0.255 | 0.173 | Neuraminidase (influenza) inhibitor | 0.173 0.005 CID_16303 | CID_16303 | |
| 0.039 | 0.277 | 0.076 | Falcipain 2 inhibitor | 0.076 0.075 CID_16303 | CID_16303 | |
| 0.039 | 0.283 | 0.08 | Falcipain inhibitor | 0.08 0.074 CID_16303 | CID_16303 | |
| 0.011 | 0.287 | 0.156 | Neuraminidase inhibitor | 0.156 0.005 CID_16303 | CID_16303 | |
| 0.049 | 0.359 | 0.122 | Aurora-C kinase inhibitor | 0.122 0.102 CID_16303 | CID_16303 | |
| 0.051 | 0.723 | 0.137 | Cyclin-dependent kinase 3 inhibitor | 0.137 0.132 CID_16303 | CID_16303 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |